Advanced Filters
noise
Found 64,920 clinical trials
N Nicholas Bobbitt

A Phase 2/3 Study to Evaluate the Efficacy and Safety of Tinlarebant in Subjects With Stargardt Disease

The goal of this clinical trial is to evaluate the safety, tolerability, and efficacy of tinlarebant in subjects with Stargardt Disease

12 - 20 years of age All Phase 2/3

AMT-116 in Patients with Solid Tumors

The purpose of this study is to evaluate the safety and efficacy of AMT-116 monotherapy in subjects with advanced solid tumors. The study is divided into two parts: the part I is dose escalation and the Part Ⅱ for expansion.

18 years of age All Phase 1/2
C Carina Friesl

EUS-directed Transenteric ERCP (EDEE) in Patients With Benign and Malignant Underlying Conditions and Inaccessible Papilla/Biliodigestive Anastomosis (BDA)

Safety and efficacy of EDEE (EUS-directed transenteric ERCP)

18 years of age All Phase N/A

PK, PD, Safety and Immunogenicity Study of Erythropoietin of Incepta Pharmaceuticals Ltd With Eprex (Janssen-Cilag).

Erythropoietin is a glycoprotein which stimulates red blood cell production. It is produced in the kidney and stimulates the division and differentiation of committed erythroid progenitors in the bone marrow. Erythropoietin, a 165 amino acid glycoprotein manufactured by recombinant DNA technology, has the same biological effects as endogenous erythropoietin. Erythropoietin …

18 years of age All Phase 3
S Study Research Coordinator

Study to Determine Optimal Dose and Evaluate Safety, Tolerability, and Pharmacokinetics of Progerinin in Patients with Hutchinson-Gilford Progeria Syndrome (HGPS)

Researchers will compare treatment with progerinin plus lonafarnib vs lonafarnib alone to assess optimal dosing, safety, tolerability, and pharmacokinetics in patients with Hutchinson-Gilford Progeria Syndrome (HGPS). Subjects in the randomized study arms will continue to take the standard of care (SOC), lonafarnib, and will be randomized to either take SOC …

1 years of age All Phase 2

PrOsPective Cohort Study for STereotactic Arhythmia Radioablation (STAR) of Refractory Ventricular Tachycardia

This is a multicenter, interventional study. The study will enroll patients that fulfill the inclusion criteria over a 33-month period. Considering the small number of patients who will meet the study criteria, it is also possible to include retrospective patients who already underwent STAR (for instance, as part of a …

18 - 85 years of age All Phase N/A
M M.Luz Sánchez-Sánchez, PhD

Effect of Dance on the Parameters of the ICF in Children With Functional Diversity

The goal of this clinical trial is to determine the effect of a therapeutic dance program developed in a school environment on different parameters of structure and function, activity and participation according to the ICF framework in children with functional diversity. Researchers will compare the effects of eight months of …

3 - 14 years of age All Phase N/A
P PhD Chung

Effects of DL-endopeptidase Producing Probiotics on Human Intestinal NOD2 Ligands and Related Functions

Probiotics are beneficial to human gut health. We found that a DL-endopeptidase producing probiotic could repair the intestinal barrier and regulate enteritis. Thus, a population-based trial was conducted.

years of age All Phase N/A
H Henriette Edemann-Callesen, Phd, MD

External Trigeminal Nerve Stimulation for Attention Deficit Hyperactivity Disorder - Feasibility Trial

The investigators will assess the use of the Monarch eTNS device as a non-pharmacological treatment for patients aged 7 to 17 years with ADHD. The investigators will compare the eTNS device to a sham device. Participants will use the device for four weeks during night time. During the trial, participants …

7 - 17 years of age All Phase N/A
H Haidong Kan, PhD

Acute Effects of Cold Exposure on Cardiovascular System

This is a randomized controlled human exposure crossover study. Investigators aim to assess the acute effects of low temperature exposure on cardiovascular system and the underlying mechanisms.

18 - 30 years of age All Phase N/A

Simplify language using AI